World Lymphoma Awareness Day 2024

September 15 is World Lymphoma Awareness Day and this year marks the 20-year anniversary of this event, with the theme centred around the emotional impact lymphoma has on someone living with the condition.

Perth Blood Institute (PBI) understands the emotional affect a blood disorder can have on individuals. It is our mission to develop safe and effective treatment options for people diagnosed with lymphoma, but just as important we provide the personal support essential for people living with lymphoma.

Gemma and Ashley are two PBI patients living with a lymphoma diagnosis.

Gemma was diagnosed with non-Hodgkin lymphoma in 2010, and after participating in clinical trials at PBI, she is in remission and enjoying life with her family. Visit our website to read Gemma's amazing journey.

Ashley has been living with mantle cell lymphoma since 2012. After joining a clinical trial, Ashley went into remission, and nearly 10 years after his diagnosis, the cancer had returned. In 2022, Ashley joined another PBI clinical trial, showing positive results. Ashley's story

At PBI we currently have clinical trials open for the following relapsed or refractory non-Hodgkin lymphoma subtypes:

  • Follicular lymphoma
  • Marginal Zone Lymphoma
  • Mantle Cell Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • Waldenstrom Macroglobulinemia
  • Small Lymphocytic Lymphoma/Chronic lymphocytic leukaemia (this can present as either lymphoma or leukaemia)

To find out more about these clinical trials, please visit our website PBI Clinical Trials.

Lymphoma is one of the main types of blood cancers, with Hodgkin lymphoma and non-Hodgkin lymphoma (NHL) being the two main subtypes.

There are several studies, and a multitude of data collected over the decades to provide the latest information about the trajectory of incidence for Hodgkin lymphoma and NHL. The literature shows that Hodgkin lymphoma has demonstrated a decline in new cases, however NHL is still on the incline.

Non-Hodgkin lymphoma and Australia

Australia, along with New Zealand have the second highest global incidence of NHL. Data also shows that NHL is higher in males compared to females.

Data – non-Hodgkin lymphoma – age-standardized (world) incidence and mortality rates (male & female) – GLOBOCAN 2022

Here are some additional facts about non-Hodgkin lymphoma from the World Health Organization; and to read more about lymphoma please visit the PBI webpage lymphoma.

Please visit the World Lymphoma Awareness Day – Lymphoma Coalition website for additional information about the day.

References